Glaukos Stock Drops on Slower iDose Growth Despite Strong Q4 Results
Glaukos shares fell 9% after Q4 iDose sales growth disappointed investors, though the company maintained its 2026 revenue guidance of $600-620 million.
NOTRELOAD AI
TG Therapeutics Stock Rises on Strong Briumvi Sales and Raised Guidance
TG Therapeutics (TGTX) boosts 2025 revenue forecast to $616M on strong Briumvi MS drug sales, projects $875M-$900M for 2026, exceeding Wall Street expectations.
GlobalFoundries Acquires Synopsys' Processor IP Business to Boost AI Chip Development
GlobalFoundries announces acquisition of Synopsys' ARC Processor IP Solutions to accelerate Physical AI development and expand RISC-V capabilities for next-gen applications.
Citigroup Q4 2025: Profits Dip Despite Strong Banking Growth
Citigroup's (C) Q4 2025 profit fell 13% due to Russia exit loss, but investment banking fees surged 35% and adjusted earnings beat estimates as CEO Fraser's turnaround gains traction.
Quantinuum Plans IPO as Quantum Computing Goes Public
Honeywell's quantum computing unit Quantinuum prepares for IPO filing with $11B valuation, backed by Nvidia and major investors for breakthrough computing technology.
China Investigates Trip.com for Alleged Monopoly Abuse Ahead of Holiday Rush
China's market regulator probes Trip.com Group for antitrust violations, accusing the dominant travel platform of abusing market power. Shares drop 6.5% as investigation unfolds.